日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mitotic MTH1 inhibitor karonudib kills epithelial ovarian cancer independent of platinum sensitivity

有丝分裂抑制剂MTH1 karonudib 可杀死上皮性卵巢癌细胞,且该作用与铂类药物敏感性无关。

Hurley, Rachel M; Wagner, Jill M; Kanakkanthara, Arun; Venkatachalam, Annapoorna; Deisinger, Aaron M; Correia, Cristina; Schneider, Paula A; Peterson, Kevin L; Macon, Elaine P; Heinzen, Ethan P; Sanjiv, Kumar; Hou, Xiaonan; Becker, Marc A; Maurer, Matthew J; Larson, Melissa C; Swisher, Elizabeth M; Li, Hu; Oberg, Ann L; Weroha, S John; Berglund, Ulrika Warpman; Helleday, Thomas; Kaufmann, Scott H; Hendrickson, Andrea E Wahner

In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma

PARP抑制剂尼拉帕尼在同源重组缺陷型和功能型卵巢癌中的体内抗肿瘤活性

AlHilli, Mariam M; Becker, Marc A; Weroha, S John; Flatten, Karen S; Hurley, Rachel M; Harrell, Maria I; Oberg, Ann L; Maurer, Matt J; Hawthorne, Kieran M; Hou, Xiaonan; Harrington, Sean C; McKinstry, Sarah; Meng, X Wei; Wilcoxen, Keith M; Kalli, Kimberly R; Swisher, Elizabeth M; Kaufmann, Scott H; Haluska, Paul

A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgrafts

一种靶向妊娠相关血浆蛋白-a的新型中和抗体可抑制患者小鼠肿瘤移植模型中卵巢癌的生长和腹水的积聚。

Becker, Marc A; Haluska, Paul Jr; Bale, Laurie K; Oxvig, Claus; Conover, Cheryl A

Dual HER/VEGF receptor targeting inhibits in vivo ovarian cancer tumor growth

双重靶向HER/VEGF受体可抑制体内卵巢癌肿瘤生长

Becker, Marc A; Farzan, Thahir; Harrington, Sean C; Krempski, James W; Weroha, S John; Hou, Xiaonan; Kalli, Kimberly R; Wong, Tai W; Haluska, Paul

IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumors.

IGFBP 比率赋予乳腺肿瘤对 IGF 靶向治疗的抵抗力,并与乳腺肿瘤侵袭性增强和预后不良相关

Becker Marc A, Hou Xiaonan, Harrington Sean C, Weroha S John, Gonzalez Sergio E, Jacob Kristina A, Carboni Joan M, Gottardis Marco M, Haluska Paul